Fetal stem cells aim to mend broken bones in infants
NCT ID NCT03706482
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial tests whether fetal stem cells given before or after birth can safely help infants with severe osteogenesis imperfecta, a genetic condition causing fragile bones and frequent fractures. Up to 18 children will receive multiple doses of the cells. The main goal is to check safety, but researchers will also track fracture rates and bone density.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fetal liver-derived mesenchymal stem cells (BOOST cells)
- What this could lead to
- If it works, this could point toward a treatment that reduces fractures and improves bone strength in children with severe brittle bone disease.
- What could go wrong
- This is a very early, small trial (18 participants) focused mainly on safety. The cells may cause immune reactions or fail to improve bone health, and long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENESIS IMPERFECTA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karolinska University Hospital
Stockholm, Stockholm County, 171 76, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dental scans and AI could spot rare bone diseases faster
- Wearable sensors shed light on movement in brittle bone disease
- BONeMOVE: exercise boosts stamina in kids with brittle bones
- New shot aims to toughen fragile bones in rare disease
- Massive database aims to unlock secrets of facial birth defects
- Radiation-Free bone scan tested in kids